(5-Cyclopropyl-1,3-oxazol-4-yl)methanol, 97%, 10g

(S)-(3-(methoxymethoxy)-2,3-dimethylbutyl)diphenylphosphine oxide, 96%, 500mg

Distributeurs ROTILABO® II, 1-10 ml, 1 pièce

4-Amino-1,2,5-oxadiazol-3(2H)-one, 98%, 5g

Methyl 1-benzylazetidine-2-carboxylate, 95.0%, 100g

Potassium (S)-2-(6-hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylate, 95.0%, 10g

4-Nitroacetanilide, 98.0%, 1g

alpha,epsilon-Dibenzoyl-DL-lysine>99.0%(T)1g

(2-Fluoro-6-formylphenyl)boronic acid, 97%, 10g

4-(4-FLUOROPHENYL)-4-PHENYLPIPERIDINE HCL, 95.0%, 1g

2-(Pyrazin-2-yl)ethanol, 95.0%, 250mg

3-Chloro-1H-indole-4-carbaldehyde, 98+%, 250mg

6-((BENZYLOXY)CARBONYL)-2-(TERT-BUTOXYCARBONYL)-2,6-DIAZASPIRO[3.4]OCTANE-8-CARBOXYLIC ACID, 95.0%, 250mg